UB Paderborn / Katalog / Suche / in CDI

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

Circulation (New York, N.Y.), 2003-09, Vol.108 (10), p.1184-1190

2003

Volltextzugriff (PDF)

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

Circulation (New York, N.Y.), 2003-09, Vol.108 (10), p.1176-1183

2003

Volltextzugriff (PDF)

Benzene and leukemia. An epidemiologic risk assessment

The New England journal of medicine, 1987-04, Vol.316 (17), p.1044

1987

Volltextzugriff (PDF)

Macular pigment optical density in a midwestern sample

Ophthalmology (Rochester, Minn.), 2001-04, Vol.108 (4), p.730-737

2001

Volltextzugriff (PDF)

Olestra Consumption Is Not Associated with Macular Pigment Optical Density in a Cross-Sectional Volunteer Sample in Indianapolis

The Journal of nutrition, 2000-03, Vol.130 (3), p.642-647

2000

Volltextzugriff (PDF)

Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial

Annals of internal medicine, 1999-02, Vol.130 (4 Pt 1), p.253

1999

Volltextzugriff (PDF)

Improving the sensitivity of in vitro skin penetration experiments

Pharmaceutical research, 1994-12, Vol.11 (12), p.1747-1754

1994

Volltextzugriff (PDF)

ESTIMATING THE MINIMUM THERAPEUTICALLY EFFECTIVE DOSE OF A COMPOUND VIA REGRESSION MODELLING AND PERCENTILE ESTIMATION

Statistics in medicine, 1995-05, Vol.14 (9), p.925-932

Filloon, Thomas G.

1995

Volltextzugriff (PDF)

Comparison of p-fluoroketorolac and [ 18O 3]ketorolac for use as internal standards for the determination of ketorolac by gas chromatography/mass spectrometry (GC/MS)

Journal of pharmaceutical and biomedical analysis, 1998-06, Vol.17 (2), p.227-231

1998

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled, Consumer Rechallenge Test of Olean Salted Snacks

Regulatory toxicology and pharmacology, 1997-10, Vol.26 (2), p.200-209

1997

Volltextzugriff (PDF)

Cutaneous injection of the capsaicin analogue, NE-21610, produces analgesia to heat but not to mechanical stimuli in man

Pain (Amsterdam), 1995-04, Vol.61 (1), p.17-26

1995

Volltextzugriff (PDF)

Cutaneous pretreatment with the capsaicin analog NE-21610 prevents the pain to a burn and subsequent hyperalgesia

Pain (Amsterdam), 1995-09, Vol.62 (3), p.373-378

1995

Volltextzugriff (PDF)

Estimating the minimum therapeutically effective dose of a compound via regression modelling and percentile estimation. Discussion

Statistics in medicine, 1995, Vol.14 (9-10), p.925-933

1995

Volltextzugriff (PDF)

Follow-Up to the Study: A Randomized, Double-Blind, Placebo-Controlled Consumer Rechallenge Test of Olean Salted Snacks

Regulatory toxicology and pharmacology, 1998-02, Vol.27 (1), p.2-2

1998

Volltextzugriff (PDF)

Confidence Intervals for Nonparametric Curve Estimates: Toward More Uniform Pointwise Coverage

Journal of the American Statistical Association, 2001-03, Vol.96 (453), p.233-246

2001

Volltextzugriff (PDF)

Follow-up to the study: A randomized, double-blind, placebo-controlled consumer rechallenge test of Olean salted snacks

Regulatory toxicology and pharmacology, 1998-02, Vol.27 (1 Pt 1), p.2

1998

Volltextzugriff (PDF)

What women want - quantifying the perception of hair amount: an analysis of hair diameter and density changes with age in caucasian women

British journal of dermatology (1951), 2012-08, Vol.167 (2), p.324-332

2012

Volltextzugriff (PDF)

Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass

The Annals of thoracic surgery, 2004-03, Vol.77 (3), p.942-949

2004

Volltextzugriff (PDF)

Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview

The American heart journal, 2006-08, Vol.152 (2), p.291-296

2006

Volltextzugriff (PDF)

Effects of wheat bran and olestra on objective measures of stool and subjective reports of GI symptoms

The American journal of gastroenterology, 2000, Vol.95 (5), p.1244-1252

2000

Volltextzugriff (PDF)

Effects of wheat bran and olestra on objective measures of stool and subjective reports of GI symptoms

The American journal of gastroenterology, 2000-05, Vol.95 (5), p.1244-1252

2000

Volltextzugriff (PDF)

Confidence intervals for non parametric curve estimates: Toward more uniform pointwise coverage

Journal of the American Statistical Association, 2001, Vol.96 (453), p.233-246

2001

Volltextzugriff (PDF)

Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. Commentary

The Annals of thoracic surgery, 2004, Vol.77 (3), p.942-950

2004

Volltextzugriff (PDF)

Robust sequential crossover designs for clinical trials

Controlled clinical trials, 1991-10, Vol.12 (5), p.694-694

1991

Volltextzugriff (PDF)

A Review of: "Sample Size Calculations in Clinical Research, Second Edition, by S.-C. Chow, J. Shao, and H. Wang": Boca Raton, FL: Chapman & Hall/CRC, 2007, ISBN 1-58488-982-9, xiv + 465 pp., $89.95

Journal of Biopharmaceutical Statistics, 2008, Vol.18 (5), p.1034-1035

Filloon, Thomas G.

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

Benzene and leukemia. An epidemiologic risk assessment

Macular pigment optical density in a midwestern sample

Olestra Consumption Is Not Associated with Macular Pigment Optical Density in a Cross-Sectional Volunteer Sample in Indianapolis

Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial

Improving the sensitivity of in vitro skin penetration experiments

ESTIMATING THE MINIMUM THERAPEUTICALLY EFFECTIVE DOSE OF A COMPOUND VIA REGRESSION MODELLING AND PERCENTILE ESTIMATION

Comparison of p-fluoroketorolac and [ 18O 3]ketorolac for use as internal standards for the determination of ketorolac by gas chromatography/mass spectrometry (GC/MS)

Randomized, Double-Blind, Placebo-Controlled, Consumer Rechallenge Test of Olean Salted Snacks

Cutaneous injection of the capsaicin analogue, NE-21610, produces analgesia to heat but not to mechanical stimuli in man

Cutaneous pretreatment with the capsaicin analog NE-21610 prevents the pain to a burn and subsequent hyperalgesia

Estimating the minimum therapeutically effective dose of a compound via regression modelling and percentile estimation. Discussion

Follow-Up to the Study: A Randomized, Double-Blind, Placebo-Controlled Consumer Rechallenge Test of Olean Salted Snacks

Confidence Intervals for Nonparametric Curve Estimates: Toward More Uniform Pointwise Coverage

Follow-up to the study: A randomized, double-blind, placebo-controlled consumer rechallenge test of Olean salted snacks

What women want - quantifying the perception of hair amount: an analysis of hair diameter and density changes with age in caucasian women

Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass

Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview

Effects of wheat bran and olestra on objective measures of stool and subjective reports of GI symptoms

Effects of wheat bran and olestra on objective measures of stool and subjective reports of GI symptoms

Confidence intervals for non parametric curve estimates: Toward more uniform pointwise coverage

Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. Commentary

Robust sequential crossover designs for clinical trials

A Review of: "Sample Size Calculations in Clinical Research, Second Edition, by S.-C. Chow, J. Shao, and H. Wang": Boca Raton, FL: Chapman & Hall/CRC, 2007, ISBN 1-58488-982-9, xiv + 465 pp., $89.95

Suchergebnisse filtern